Peptide Purity vs Potency: What a COA Actually Measures

Peptide purity vs potency is the most common source of confusion on a research peptide certificate of analysis, and it starts with a simple mistake: treating one headline percentage as if it answered every quality question. A COA can report 99% purity for a vial in which only about three-quarters of the powder is actually peptide, and in which the peptide’s biological activity has never been measured at all. None of those statements contradict each other. Purity, net peptide content, identity, and potency are four different measurements, made by four different methods, answering four different questions — and a researcher who conflates them will miscalculate concentrations, misjudge batches, and misread otherwise honest documentation.

This guide separates the four numbers, shows the arithmetic that connects them, and explains what each test on a COA can and cannot prove. Everything here concerns laboratory research material supplied strictly for research use only.

The four questions a COA is really answering

When researchers argue about peptide purity vs potency, they are usually mixing up measurements that belong in separate rows of the same table:

Only the last row is potency in the strict sense. In everyday supplier language, “potency” is sometimes used loosely to mean net peptide content — how much peptide is in the vial — which is part of why the vocabulary confuses people. In this article, potency means measured activity, content means mass fraction, and purity means chromatographic cleanliness. Keeping those three words apart is most of the battle.

Purity: a property of the chromatogram, not of the vial

HPLC purity is calculated as the area of the main peak divided by the total area of all detected peaks, multiplied by 100. Reversed-phase HPLC separates the sample largely by hydrophobicity, and detection at 214–220 nm reads absorbance from the peptide bond itself, so most peptide-related species register. The impurities that lower the number are real synthesis and handling products: deletion sequences missing one residue, truncated chains, oxidized residues, incompletely deprotected species, and closely related byproducts of solid-phase synthesis.

What purity does not measure is just as important:

• Water and salts are invisible. Water, trifluoroacetate (TFA), acetate, chloride, and inorganic salts do not absorb meaningfully at the detection wavelength once past the injection void, so they contribute mass to the vial but no area to the chromatogram.
• Area percent is not mole percent. UV response differs by residue. A tryptophan-containing impurity absorbs far more strongly at low UV wavelengths than an impurity that has lost its aromatic residues, so some impurities are over-counted and others under-counted relative to their molar share.
• Co-elution hides species. An impurity that travels with the main peak under one gradient may only separate under a different column or gradient — one reason the chromatogram itself, not just the percentage, is worth inspecting. Our HPLC purity testing guide walks through reading that trace peak by peak.
• Some damaging changes are chromatographically quiet. Racemized (D-form) residues have the same mass and often very similar retention, and deamidation shifts mass by only about +0.98 Da. A high purity figure does not exclude either.

So a statement like “99% pure” is precise but narrow: of the UV-detected peptide material in that injection, 99% of the peak area belonged to the intended product peak, under that method, on that day.

Net peptide content: how much of the powder is peptide

A lyophilized peptide is not a pile of free peptide molecules. It is a salt. During synthesis and purification — typically involving TFA-containing mobile phases — positively charged residues (arginine, lysine, histidine, the free N-terminus) pick up counter-ions, and the freeze-dried cake retains bound water because peptides are hygroscopic. The gross powder therefore contains three kinds of mass: peptide, counter-ions, and water, plus small residuals.

Net peptide content states what fraction of that gross mass is peptide. For lyophilized TFA salts it commonly falls somewhere around 70–90%, and sequences rich in basic residues — which carry more counter-ions — naturally sit lower. That is chemistry, not adulteration. Established ways to measure it include:

• Amino acid analysis (AAA): the sample is hydrolyzed and its stable amino acids quantified against standards, back-calculating total peptide mass. A long-standing reference method, though it destroys the sample and handles some residues (such as tryptophan) poorly under acid hydrolysis.
• Elemental analysis: nitrogen content is measured and converted to peptide content using the sequence’s known nitrogen fraction.
• Quantitative NMR (qNMR): signal integrals against a certified internal standard give an absolute content figure and can simultaneously reveal counter-ion signals.
• Calibrated UV or HPLC assay against a reference standard: measures content of the target peak specifically, provided the standard itself has an assigned content.

Water is usually reported separately by Karl Fischer titration, and counter-ion content (for example residual TFA) can be measured in its own right — relevant because TFA is not biologically inert in sensitive cell-based systems, which is one reason some laboratories prefer acetate-exchanged material for cell work. The full line-by-line framework for checking these fields is in our guide to how to read a certificate of analysis.

The arithmetic: combining purity and content

Neither number alone tells you how much correct peptide is in a vial. Together, they do:

Correct target peptide mass = gross powder mass × net peptide content × HPLC purity

Worked example, using round, realistic figures:

A researcher who weighs out the full 10 mg assuming it is all target peptide overestimates the amount by roughly 30% in this example — before any question of activity is even asked. For quantitative laboratory work, where stock solutions are prepared to a target molar concentration, that error propagates into every dilution that follows. This is the practical core of peptide purity vs potency discussions: the purity figure never enters the mass calculation by itself, and skipping the content figure is the single most common concentration error in peptide research.

The reverse comparison matters when sourcing. Two batches can both honestly report 99% HPLC purity while differing substantially in net content because one carries more counter-ion and water. Comparing them on purity alone — or on price per labeled milligram alone — compares powder, not peptide. When comparing options in the research peptides at Apex Bio catalog or anywhere else, batch-specific documentation that reports both numbers is what makes a like-for-like comparison possible.

Potency proper: activity is measured, not inferred

Potency, strictly defined, is biological activity per unit mass in a specified assay. Unlike purity and content, it cannot be read off a chromatogram, because chemical integrity and functional activity are related but not identical:

• Degradation can cut activity before it cuts the headline purity number. Oxidation of methionine or tryptophan, deamidation of asparagine, hydrolysis at labile bonds, and disulfide scrambling in cystine-containing peptides can all reduce or abolish activity in a receptor or cell system. Some of these changes produce visible new HPLC peaks; others are subtle, and a partially degraded batch can still present a respectable main-peak percentage while performing poorly in a functional assay.
• Appearance proves nothing. A clear, colorless, fully dissolved solution can contain oxidized or deamidated material. Degradation is molecular, not visual.
• Activity is assay-specific. A binding assay, a cell-signaling readout, and an enzymatic assay can rank the same two batches differently, because each is sensitive to different failure modes. There is no universal “potency percent” independent of the system used to measure it.
• Time and handling are variables. A COA is a dated snapshot from the day of analysis. Oxidation, hydrolysis, and deamidation continue afterward, at rates set by temperature, moisture, light, and freeze-thaw history — which is why peptide storage best practices are part of quality, not an afterthought.

For most research peptides, routine COAs do not include a functional potency assay at all — they report identity, purity, and sometimes content. That is a legitimate scope for a research reagent document, as long as nobody upgrades it in their head into an activity guarantee. If a research question genuinely depends on activity, the laboratory needs its own functional readout, with a reference batch run alongside, rather than an inference from purity.

Identity: the fourth number that holds the others up

None of the above means anything if the molecule is wrong. Mass spectrometry supplies the identity check: the observed molecular mass must match the mass calculated from the intended sequence, within the instrument’s stated accuracy. MS identifies but does not quantify purity or content — ionization efficiency varies too much between species for peak height in a spectrum to serve as a purity measure — which is why a complete COA pairs MS with HPLC rather than substituting one for the other. Our guide to peptide mass spectrometry covers charge-state deconvolution, adducts, and the common mass shifts (oxidation +15.99 Da, deamidation +0.98 Da, disulfide formation −2.02 Da) that let a spectrum double as a degradation check.

A practical checklist for comparing two COAs

1. Match the lot number on the COA to the lot on the vial label. A generic, lot-free document describes no specific batch.
2. Find both percentages. Purity without content leaves the mass question unanswered; content without purity leaves the cleanliness question unanswered.
3. Check the chromatogram is present, with column, gradient, and detection wavelength stated — not just a typed percentage.
4. Confirm identity data: expected vs observed mass, and the method used.
5. Note salt form and water content if reported, especially for sequences with many basic residues or for cell-based work sensitive to residual TFA.
6. Check the analysis date and the issuing laboratory. A dated, batch-specific, independently issued document carries more weight than an undated in-house summary — the reasoning is set out in our overview of COA & third-party testing at Apex Bio.
7. Do the multiplication before preparing stock: gross mass × content × purity is the amount of correct peptide you actually have.

Frequently asked questions

Can a peptide be 99% pure but contain much less than 99% peptide? Yes, routinely. HPLC purity describes the composition of the UV-detected peptide fraction. Net peptide content describes how much of the total powder is peptide at all, after counter-ions and water. A batch at 99% purity and 78% net content is internally consistent — and contains about 7.7 mg of correct peptide per 10 mg of powder.

Is low net peptide content a sign of a bad batch? Not by itself. Counter-ion load follows from the sequence: peptides with several arginine, lysine, or histidine residues carry more counter-ions and naturally report lower content. What matters is that the figure is measured and reported, so concentrations can be calculated correctly — not that it approaches 100%, which lyophilized peptide salts generally do not.

Does higher purity mean higher potency? No. Purity and potency answer different questions. Higher purity means fewer peptide-related impurities in the fraction; potency is activity in a defined assay, which also depends on degradation state and handling history. A very pure batch stored badly can lose activity, and purity alone cannot detect that loss.

Which number should I use to calculate a stock solution concentration? Use net peptide content, combined with purity: target peptide mass = gross mass × NPC × purity. Calculating from gross powder weight alone systematically overstates concentration, commonly by 15–30% for TFA salts.

Why doesn’t every COA report net peptide content? Content assays such as amino acid analysis cost more and consume sample, so many research-grade COAs report identity and HPLC purity only. That omission does not make a COA false, but it does mean the mass-per-vial question is unanswered — a gap worth knowing about before quantitative work, and a fair question to put to any supplier.

Related in the Apex shop: COA & third-party testing at Apex Bio — supplied strictly for laboratory research use.

Research Use Only disclaimer: All Apex Bio Industries products are supplied strictly for laboratory research use only. They are not intended for human or veterinary use, consumption, diagnosis, or treatment of any condition, and nothing in this article is medical advice, dosing guidance, or a recommendation for use outside a laboratory research setting. Potency in this article refers solely to activity measured in laboratory assay systems.